Home/ Stocks/ IGC

IGC Pharma, Inc.

IGC XASE

$0.27 -0.00 (-0.60%) ▼ 15-min delayed

Open

$0.27

High

$0.29

Low

$0.27

Volume

706.9K

Market Cap

$27.52M

About IGC Pharma, Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 70 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$317.0K	$-2,402,000	$-0.02
Q2 2026	$191.0K	$-1,821,000	$-0.02
FY 2025	$1.27M	$-7,121,000	$-0.09
Q2 2025	$412.0K	$-1,717,000	$-0.02

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 12, 2026

Calendar →

Related Market News

No specific coverage for IGC yet. Check out our latest market news or earnings calendar.

Get IGC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on IGC Pharma, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.